# Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors

> **NCT01290471** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 36 (actual)

## Conditions studied

- Advanced Solid Malignant Tumors
- Advanced Ovarian Cancer

## Interventions

- **DRUG:** U3-1565

## Key facts

- **NCT ID:** NCT01290471
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2014-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01290471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01290471, "Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01290471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*